MeHow Innovative Ltd. announces a **CNY 0.60 per 10 shares** cash dividend (tax included) for its third-quarter 2026 profits, approved at an extraordinary general meeting. The distribution reflects the company’s profit-sharing strategy for shareholders. The dividend proposal follows a prior extraordinary meeting held in November 2026.
MeHow Innovative Ltd. reports **CNY 1.36 billion in sales and revenue** for the nine months ending September 30, 2026, marking an increase from **CNY 1.19 billion** in the same period the prior year. The company’s financial results reflect growth in its core operations over the latest quarterly cycle.
Mehow Innovative Ltd. has a lock-up agreement on its A Shares that expires on **October 12, 2026**. The restriction limits early trading of shares post-IPO or funding rounds. The company’s stock rating reflects composite metrics including valuation, EPS revisions over four months, and visibility scores.
MeHow Innovative Ltd. reports **CNY 810.16 million in sales** and **CNY 813.21 million in revenue** for the half-year ended June 30, 2026. This marks year-over-year growth compared to CNY 729.75 million in sales and CNY 732.82 million in revenue for the same period in 2025. The company highlights increased financial performance in its latest earnings update.
MeHow’s Shenzhen stock market listing creates China’s newest medical device billionaire. The company specializes in advanced medical technologies, including surgical robots and diagnostic tools. The listing follows a surge in demand for high-precision medical devices in China’s growing healthcare sector.
MeHow Innovative
MeHow Innovative is a medical device CDMO serving the medical device industry under the MAH system.